High-efficacy therapy and progression independent of relapse and MRI activity in multiple sclerosis
Brain · 03.06.2026 · 149 (6) · 1807-1809
DOI: 10.1093/brain/awag175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 28.05.2026. Verfasst von Carmen Tur. Beteiligte Einrichtung: Multiple Sclerosis Centre of Catalonia (Cemcat), Neurology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, …. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
This scientific commentary refers to ‘Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosis’ by Rollot et al. (https://doi.org/10.1093/brain/awag060).
Autor:innen und Institutionen
- Multiple Sclerosis Centre of Catalonia (Cemcat), Neurology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Centro de Investigación Biomédica en Red (CIBER), ISCIII, 28029 Madrid, Spain.
ORCID-Profile: Carmen Tur
Zitieren
APA
Tur, C. (2026). High-efficacy therapy and progression independent of relapse and MRI activity in multiple sclerosis. Brain, 149(6), 1807-1809. https://doi.org/10.1093/brain/awag175
Vancouver
Tur C. High-efficacy therapy and progression independent of relapse and MRI activity in multiple sclerosis. Brain. 2026;149(6):1807-1809. doi:10.1093/brain/awag175
BibTeX
@article{Tur2026,
author = {Tur, Carmen},
title = {High-efficacy therapy and progression independent of relapse and MRI activity in multiple sclerosis},
journal = {Brain},
year = {2026},
volume = {149},
number = {6},
pages = {1807--1809},
doi = {10.1093/brain/awag175}
}
EUVIMED